R&D (research and development) SMEs (small and medium-sized companies) urged to exploit EU innovation network:
This article was originally published in Clinica
Executive Summary
The UK government is urging companies involved in R&D with innovative technologies to use the technology transfer support services of the Innovation Relay Centre (IRC) network. The network of 68 IRCs was created to facilitate innovative technology transfer especially between small and medium-sized companies (SMEs). It spans 30 regions and countries, including the EU, Bulgaria, Czech Republic, Cyprus, Estonia, Hungary, Iceland, Israel, Latvia, Lithuania, Norway, Poland, Romania, Slovak Republic, Slovenia and Switzerland. Life sciences, genetics and biotechnology comprise one of the seven priority themes of the EU's current R&D programme (FP6). The others include nanotechnology and IT.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.